Author/Authors :
Mansouri-Tehrani, Hajar-Alsadat Departments of Biotechnology and Biology - University of Isfahan , Rabbani-Khorasgani, Mohammad Departments of Biotechnology and Biology - University of Isfahan , Hosseini, Sayyed Mohsen Isfahan University of Medical Sciences, Isfahan , Mokarian, Fariborz Isfahan University of Medical Sciences, Isfahan , Mahdavi, Hoda Isfahan University of Medical Sciences, Isfahan , Roayaei, Mahnaz Isfahan University of Medical Sciences, Isfahan
Abstract :
Background: Radiotherapy is frequently used in treatment approaches of pelvic malignancies. Nevertheless, it has some known systemic
effects on blood cells and the immune system that possibly results in their susceptibility to infection. Probiotics are live microbial food
ingredients that provide a health advantage to the consumer. Honey has prebiotic properties. The aim of this clinical trial was to investigate
probable effects of probiotic or probiotics plus honey on blood cell counts and serum IgA levels in patients receiving pelvic radiotherapy.
Materials and Methods: Sixty-seven adult patients with pelvic cancer were enrolled. Patients were randomized to receive either: (1) Probiotic
capsules (including: Lactobacillus casei, Lactobacillus acidophilus, Lactobacillus rhamnosus, Lactobacillus bulgaricus, Bifidobacterium
breve, Bifidobacterium longum, and Streptococcus thermophiles) (n = 22), (2) probiotic capsules plus honey (n = 21) or (3) placebo capsules
(n = 24) all for 6 weeks. Blood and serum samples were collected for one week before radiotherapy and 24-72 h after the end of radiotherapy.
Results: White blood cells (WBC), red blood cells (RBC), platelet counts, and serum IgA level were not significantly changed in patients
taking probiotic (alone or plus honey) during pelvic radiotherapy. The mean decrease in RBC count was 0.52, 0.18, and 0.23 × 106 cells/μL,
WBC count was 2.3, 1.21, and 1.34 × 103 cells/μL and platelet count was, 57.6, 53.3, and 66.35 × 103 cells/μL for the probiotic, probiotic plus
honey, and placebo groups, respectively. The mean decrease of serum IgA was 22.53, 29.94, and 40.73 mg/dL for the probiotic, probiotic plus
honey, and placebo groups, respectively. Conclusion: The observed nonsignificant effect of probiotics may be in favor of local effects of this
product in the gut rather than systemic effects, however, as a trend toward a benefit was indicated, further studies are necessary in order to
extract effects of probiotics or probiotic plus honey on hematologic and immunologic parameters in patients receiving pelvic radiotherapy
Keywords :
serum IgA , pelvic cancer , honey radiotherapy , probiotic prebiotic , Blood cell counts